PROVIDER PROFILE · NPI 1073803813
Sarah HemeidaMD, MPH
PRESCRIBING · PART D · 2024
Total Rx claims
260
Beneficiaries
—
Total drug cost
$4K
Distinct drugs
15
Brand share
10.4%
Top prescribed drugs
Amlodipine Besylate40 claims
Atorvastatin Calcium26 claims
Losartan Potassium25 claims
Lisinopril21 claims
Gabapentin18 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Sarah Hemeida's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| DENVER HEALTH AND HOSPITAL AUTHORITY | 12 | 37 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE